Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: A Study of LY2216684 in Healthy Females [Phase 1]

View source ↗

Summary

Phase 1 trial of LY2216684 in healthy females completed; study related to depressive disorder conditions (Major Depressive Disorder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2216684

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED | Results posted: 2018-10-23